<DOC>
	<DOCNO>NCT01286064</DOCNO>
	<brief_summary>The aim present prospective study investigate fluorescence emission human blood plasma patient colorectal cancer . For year , serum tumor marker study diagnosis follow-up colorectal cancer , among carcinoembryonic antigen ( CEA ) achieve promising result . However , sensitivity CEA colorectal cancer le 25 % elevate CEA level also occur patient benign disease , well patient carcinomas . Nevertheless , surveillance program often base CEA test combination marker present matter research . Alternative method base optical fluoroscopy introduce experimental stage clinical diagnosis cancer . Few study report application native fluorescence spectroscopy biofluids diagnosis tumoral disease . The reported finding prompt u investigate fluorescence emission human blood plasma patient colorectal cancer . For purpose , blood patient collect fluorescence Preliminary measurement plasma patient bear colon cancer show fluorescence spectra mainly characterize presence emission peak 620-630 nm , whose excitation spectrum peak 405 nm . Hence , excitation wavelength 405 nm select study . The fluorescence emission spectrum record range 430-700 nm .</brief_summary>
	<brief_title>Colorectal Cancer Detection Means Optical Fluoroscopy</brief_title>
	<detailed_description>Eligibility criterion : Gastrointestinal disease clinical symptom related colorectal cancer risk submit endoscopy . Exclusion criterion consist age young 18 year , history psychiatric illness , preoperative radiotherapy . Outcome : investigate possible role native fluorescence blood plasma management colorectal cancer ( CRC ) feasibility new tumor marker . Sample blood collect asymptomatic blood donor CRC patient . The native fluorescence blood plasma measure use conventional spectrofluorimeter .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<criteria>Gastrointestinal disease clinical symptom related colorectal cancer risk endoscopy Age young 18 year 75 year , history psychiatric illness , preoperative chemo/radiotherapy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>adenocarcinoma ,</keyword>
	<keyword>colorectal tumor ,</keyword>
	<keyword>endogenous porphyrin ,</keyword>
	<keyword>fluorescence ,</keyword>
	<keyword>tumor marker .</keyword>
</DOC>